Pacific Biosciences of California Inc (NASDAQ:PACB) currently has a daily average trading volume of 9.89M but it saw 12255296 shares traded in last market. With a market cap of 460.15M USD, the company’s current market price of $1.69 came rising about 2.42 while comparing to the previous closing price of $1.65. In past 52 weeks, the stock remained buoying in the range of price level as high as $14.55 and as low as $1.25.
Taking a look at 20-day trading activity of Pacific Biosciences of California Inc (PACB) gives us an average price of $2.2222, while its current price level is -88.38% below from 52-week high level whereas it is 35.20% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $3.4670 while that of 200 days or SMA-200 reads an average of $7.5729. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.89% during that period while stretching the period over a month that increases to 13.20%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 30.26 which implies that the stock is in neutral territory.
Goldman downgraded its recommendation for the stock as a “Neutral” from “Buy” on April 18, 2024 while assigning a price target range of $7-$2.50. Stephens issued its recommendations for the stock as it initiated the price target for the stock is $11.
Over the week, PACB’s stock price is moving 24.26% up while it is -50.44% when we observe its performance for the past one month. Year-to-date it is -82.77% down and over the past year, the stock is showing a downside performance of -85.06%.
Currently, Pacific Biosciences of California Inc’s total number of outstanding shares is 267.74M. Company’s return on investment (ROI) stands at -18.87% and return on equity (ROE) at -48.53%. Stock’s beta reads 1.98. Stock has a price to book (P/B) ratio of 0.65 while price to sale or P/S ratio amounts to 2.30. Its return on asset (ROA) is -17.46% on average.
